Health Care & Life Sciences » Biotechnology | Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.03
Market Cap
HKD469.84 M
Shares Outstanding
426 M
Public Float
-

Profile

Address
18th Floor, United Centre
Hong Kong
Hong Kong
Employees -
Website http://www.interlong.com
Updated 07/08/2019
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. It operates through the following segments: Manufacturing and Selling of Medicines; Sales and Distribution of Medicines and Healthcare Products; and Provision of Research and Development Services of Modern Biological Technology. The company was founded on November 15, 1994 and is headquartered in Hong Kong.

Financials

View All
Created with Highcharts 5.0.14Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.Net Income. Fiscal year is January-December. All values HKD Thousands.45 23845 23841 75041 75025 97025 97073 25073 25057 95057 9505757201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Thousands.771 750771 750815 864815 864889 766889 766886 959886 959911 268911 2681 0271 0272013201420152016201720180250k500k750k1 000k

Feng Zhang
Chairman & Compliance Officer
Yan He Xu
General Manager & Executive Director